109 filings
Page 2 of 6
8-K
x7wkl8yb ac06
9 Jun 22
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
qcu8cm6u9
5 May 22
Protara Therapeutics Announces First Quarter 2022 Financial Results and Business Overview
8:15am
8-K
x8rlxr6erm
9 Mar 22
Protara Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Business Overview
7:47am
8-K
fersp2md91xldrjx0
10 Jan 22
Protara Therapeutics Announces Appointment of Jathin Bandari, M.D. as Chief Medical Officer
8:23am
8-K
yv4sh
4 Nov 21
Protara Therapeutics Announces Third Quarter 2021 Financial Results and Business Overview
8:09am
8-K
cfenz7b 34
18 Oct 21
Departure of Directors or Certain Officers
5:01pm
8-K
7jy1td12 io
12 Oct 21
Regulation FD Disclosure
7:25am
8-K
ornjsco5v jlsges
5 Aug 21
Protara Therapeutics Announces Second Quarter 2021 Financial Results and Business Overview
8:01am
8-K
ta6ylx z5aas
10 Jun 21
Protara Therapeutics Announces Appointment of Jane Huang, M.D. to Board of Directors
8:11am
8-K
umt7pg8zq4
23 Apr 21
Protara Therapeutics Provides Regulatory Update for TARA-002 for the Treatment of Lymphatic Malformations
7:01am
8-K
2o4kl
19 Apr 21
Protara Therapeutics Announces Appointment of MartÃn Sebastian Olivo, M.D. as Chief Medical Officer
4:30pm
8-K
3nxa3g4x
17 Mar 21
Changes in Registrant's Certifying Accountant
5:14pm
8-K
hn7 7wwtri6
3 Mar 21
Other Events
8:01am
8-K
ae9hb4qr6
11 Feb 21
Corporate Presentation February 2021
8:01am
8-K
q28e47xo 3z
2 Feb 21
Protara Therapeutics Announces Appointment of Cynthia Smith to Board of Directors
8:15am
8-K
zdcntt hw6b270wa
8 Dec 20
Entry into a Material Definitive Agreement
4:41pm
8-K
pzqlo3ere739d9
7 Dec 20
Departure of Directors or Certain Officers
4:30pm
8-K
6xlqs96pl3rk3eh
17 Nov 20
Other Events
9:01am
8-K/A
9rs1es518jcj2it6nqvx
8 Oct 20
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
qrdd ej02
23 Sep 20
Protara Therapeutics Announces Proposed Concurrent Public Offerings of Common Stock and Preferred Stock
9:08am